ACI Paragraph IV Disputes
ACI Conference Institute - Hatch-Waxman Litigation
Oct
16
2024
Date: October 16, 2024
Time: 3:30PM - 4:15PM (CST)
Location: Hyatt Regency McCormick Place - Chicago
Member, Vanessa Yen, will be speaking at the conference on a panel titled, Anticipating the Impact of AI on Drug Discovery and Future Hatch-Waxman Litigation. The panel will cover:
- Exploring current and future opportunities to leverage AI in life sciences and IP and understanding how this may influence Hatch-Waxman litigation
- Drug discovery
- Patent prosecution
- E-discovery
- Examining how in house counsel and outside firms using AI in Paragraph IV litigation
- Identifying the risks of using publicly available AI for inventorship
- Complying with USPTO rules when using AI
- Drafting legal submissions for the PTAB
- Determining the level of human involvement required for an AI assisted invention to be patentable
- Anticipating where future litigation on AI assisted inventorship could arise and potential defenses
Speakers
Vanessa Yen
Panelist
Vanessa Yen, a Member at Mintz, is a sought-after and highly accomplished trial lawyer and strategist who achieves successful results in high-stakes business and IP litigations for clients in the technology, life sciences, pharmaceutical, and chemical sectors. Her practice encompasses complex patent litigations and disputes, Hatch-Waxman and biosimilar matters, IPRs, licensing controversies and arbitrations, strategic IP assessment, and IP counseling.